Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups
スポンサーリンク
概要
- 論文の詳細を見る
- 2013-01-01
著者
-
KAWANO Fumio
National Hospital Organization Kumamoto Medical Center
-
Horibe Keizo
Clinical Research Center National Hospital Organization Nagoya Medical Center
-
Nagai Hirokazu
Clinical Research Center for Blood Diseases, National Hospital Organization Nagoya Medical Center
-
WATANABE Tomoyuki
Faculty of Psychological and Physical Science, Aichi Gakuin University
-
UIKE Naokuni
National Hospital Organization Kyushu Cancer Center
-
SHIMOMURA Takeshi
National Hospital Organization Hiroshima-nishi Medical Center
-
KIHARA Rika
Clinical Research Center, National Hospital Organization Nagoya Medical Center
-
YANO Takahiro
National Hospital Organization Tokyo Medical Center
-
OKAMURA Seiichi
National Hospital Organization Kyushu Medical Center
-
HANADA Shuichi
National Hospital Organization Kagoshima Medical Center
-
SUNAMI Kazutaka
National Hospital Organization Okayama Medical Center
-
INOUE Nobumasa
National Hospital Organization Osaka Medical Center
-
SAWAMURA Morio
National Hospital Organization Nishigunma National Hospital
-
YOSHIDA Shin-ichiro
National Hospital Organization Nagasaki Medical Center
-
KITANO Kiyoshi
National Hospital Organization Matsumoto Medical Center
-
KOJIMA Yuki
Clinical Research Center, National Hospital Organization Nagoya Medical Center
関連論文
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Two rare MPL gene mutations in patients with essential thrombocythemia
- The status of antithymocyte globulin therapy for adult patients in Japan : retrospective analysis of a nationwide survey
- Prognostic significance of the BAALC isoform pattern and CEBPA mutations in pediatric acute myeloid leukemia with normal karyotype : a study by the Japanese Childhood AML Cooperative Study Group
- Outcome of bone marrow transplantation from HLA-identical sibling donor in children with hematological malignancies using methotrexate alone as prophylaxis for graft-versus-host disease
- Actual status of AIDS-related lymphoma management in Japan
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood : report from the Japanese Pediatric Leukemia/Lymphoma Study Group
- Flow cytometric analysis of de novo acute myeloid leukemia in childhood : report from the Japanese Pediatric Leukemia/Lymphoma Study Group
- Frequent DNA Methylation but not Mutation of the ID4 Gene in Malignant Lymphoma
- RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse : a study of the Japanese Childhood AML Cooperative Study Group
- High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia : a study of the Japanese Childhood AML Cooperative Study Group
- Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups
- Incidence and survival rates of hematological malignancies in Japanesechildren and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology